Genitourinary Drugs Market Size, Share & Trends Report

Genitourinary Drugs Market (2024 - 2030) Size, Share & Trends Analysis Report By Indication (Prostate, Ovarian, Bladder, Cervical Cancer, UTI & STD), By Product (Hormonal Therapy, Gynecological), By Region, And Segment Forecasts

Market Segmentation

Genitourinary Drugs Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Prostate cancer
- Ovarian cancer
- Bladder cancer
- Cervical cancer
- Renal cancer
- Erectile dysfunction
- Urinary tract infections
- Urinary incontinence & overactive bladder
- Sexually transmitted diseases
- Interstitial cystitis
- Hematuria
- Benign prostatic hyperplasia
Genitourinary Drugs Product Outlook (Revenue, USD Million, 2018 - 2030)
- Urologicals
- Hormonal therapy
- Gynecological
- Anti-infectives
- Others
Genitourinary Drugs Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Genitourinary Drugs Market, Indication Outlook
    - Prostate cancer
    - Ovarian cancer
    - Bladder cancer
    - Cervical cancer
    - Renal cancer
    - Erectile dysfunction
    - Urinary tract infections
    - Urinary incontinence & overactive bladder
    - Sexually transmitted diseases
    - Interstitial cystitis
    - Hematuria
    - Benign prostatic hyperplasia
  - North America Genitourinary Drugs Market, Product Outlook
    - Urologicals
    - Hormonal therapy
    - Gynecological
    - Anti-infectives
    - Others
  - U.S.
    - U.S. Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - U.S. Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
  - Canada
    - Canada Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - Canada Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
- Europe
  - Europe Genitourinary Drugs Market, Indication Outlook
    - Prostate cancer
    - Ovarian cancer
    - Bladder cancer
    - Cervical cancer
    - Renal cancer
    - Erectile dysfunction
    - Urinary tract infections
    - Urinary incontinence & overactive bladder
    - Sexually transmitted diseases
    - Interstitial cystitis
    - Hematuria
    - Benign prostatic hyperplasia
  - Europe Genitourinary Drugs Market, Product Outlook
    - Urologicals
    - Hormonal therapy
    - Gynecological
    - Anti-infectives
    - Others
  - UK
    - UK Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - UK Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
  - Germany
    - Germany Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - Germany Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
  - France
    - France Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - France Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
  - Italy
    - Italy Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - Italy Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
  - Spain
    - Spain Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - Spain Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
  - Sweden
    - Sweden Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - Sweden Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
  - Norway
    - Norway Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - Norway Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
  - Denmark
    - Denmark Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - Denmark Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
- Asia Pacific
  - Asia Pacific Genitourinary Drugs Market, Indication Outlook
    - Prostate cancer
    - Ovarian cancer
    - Bladder cancer
    - Cervical cancer
    - Renal cancer
    - Erectile dysfunction
    - Urinary tract infections
    - Urinary incontinence & overactive bladder
    - Sexually transmitted diseases
    - Interstitial cystitis
    - Hematuria
    - Benign prostatic hyperplasia
  - Asia Pacific Genitourinary Drugs Market, Product Outlook
    - Urologicals
    - Hormonal therapy
    - Gynecological
    - Anti-infectives
    - Others
  - Japan
    - Japan Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - Japan Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
  - China
    - China Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - China Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
  - India
    - India Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - India Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
  - Australia
    - Australia Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - Australia Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
  - Thailand
    - Thailand Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - Thailand Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
  - South Korea
    - South Korea Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - South Korea Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
- Latin America
  - Latin America Genitourinary Drugs Market, Indication Outlook
    - Prostate cancer
    - Ovarian cancer
    - Bladder cancer
    - Cervical cancer
    - Renal cancer
    - Erectile dysfunction
    - Urinary tract infections
    - Urinary incontinence & overactive bladder
    - Sexually transmitted diseases
    - Interstitial cystitis
    - Hematuria
    - Benign prostatic hyperplasia
  - Latin America Genitourinary Drugs Market, Product Outlook
    - Urologicals
    - Hormonal therapy
    - Gynecological
    - Anti-infectives
    - Others
  - Brazil
    - Brazil Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - Brazil Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
  - Mexico
    - Mexico Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - Mexico Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
  - Argentina
    - Argentina Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - Argentina Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
- Middle East and Africa
  - Middle East and Africa Genitourinary Drugs Market, Indication Outlook
    - Prostate cancer
    - Ovarian cancer
    - Bladder cancer
    - Cervical cancer
    - Renal cancer
    - Erectile dysfunction
    - Urinary tract infections
    - Urinary incontinence & overactive bladder
    - Sexually transmitted diseases
    - Interstitial cystitis
    - Hematuria
    - Benign prostatic hyperplasia
  - Middle East and Africa Genitourinary Drugs Market, Product Outlook
    - Urologicals
    - Hormonal therapy
    - Gynecological
    - Anti-infectives
    - Others
  - South Africa
    - South Africa Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - South Africa Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
  - Saudi Arabia
    - Saudi Arabia Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - Saudi Arabia Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
  - UAE
    - UAE Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - UAE Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others
  - Kuwait
    - Kuwait Genitourinary Drugs Market, Indication Outlook
      - Prostate cancer
      - Ovarian cancer
      - Bladder cancer
      - Cervical cancer
      - Renal cancer
      - Erectile dysfunction
      - Urinary tract infections
      - Urinary incontinence & overactive bladder
      - Sexually transmitted diseases
      - Interstitial cystitis
      - Hematuria
      - Benign prostatic hyperplasia
    - Kuwait Genitourinary Drugs Market, Product Outlook
      - Urologicals
      - Hormonal therapy
      - Gynecological
      - Anti-infectives
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments